Taipei, The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) announced Thursday afternoon that Taiwan's Food and Drug Administration (FDA) has been made an official member, the FDA head said the same day.
FDA Director General Wu Shou-mei (???) said ICH was established in 1990 by regulatory authorities and pharmaceutical industries in Europe, Japan and the United States.
Through global discussion, it has formulated drug regulatory guidelines that are accepted by countries around the world and recognized as global standards for drug review, Wu added.
Being an official member of the ICH shows that the international community recognizes Taiwan's strength and hard work; and feels Taiwan can make a valuable contribution, Wu noted.
Membership ensures Taiwan's pharmaceutical regulations will not only remain up to date internationally and also help raise local industry standards, Wu said, adding that it will benefit Taiwan pharmaceutical businesses that want to enter the international market.
Before becoming an official member, Taiwan's FDA first became an ICH observer in 2016, Wu added.
Taiwan's FDA is the 10th national regulatory body to join the ICH. Other members include Brazil's Health Regulatory Agency, China's Food and Drug Administration, the European Commission, US Food and Drug Administration, Health Canada, Singapore's Health Sciences Authority, South Korea's Ministry of Food and Drug Safety, Japanese Ministry of Health, Labour and Welfare's Pharmaceuticals and Medical Devices Agency, as well as Switzerland's Swissmedic, ICH's website indicates.
Source: Focus Taiwan News Channel